RACE ONCOLOGY LTD

1.11%

$1.34

Market Cap $231.9M

Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag

Subject

RAC

Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial

20/06/25

19K

20/06/25

Last post NTinvest

19K

RAC Biotech

RAC - Charts & Price Action

437 438 439

20/06/25

26K

9.7M

20/06/25

Last post NTinvest

26K

9.7M

RAC

Industry news

51 52 53

20/06/25

3.1K

1.0M

20/06/25

Last post nextdl

3.1K

1.0M

RAC

RAC media coverage

42 43 44

20/06/25

2.6K

931K

20/06/25

Last post DrSanchez

2.6K

931K

RAC

Chat GPT Q&A

6 7 8

20/06/25

444

166K

20/06/25

Last post ma420

444

166K

RAC

Ann: Termination of City of Hope Global IP License

2 3

19/06/25

152

41K

19/06/25

Last post ma420

152

41K

RAC

General Comments / Chat

220 221 222

19/06/25

13K

4.8M

19/06/25

Last post Teeth

13K

4.8M

RAC

Ann: Application for quotation of securities - RAC

19/06/25

527

19/06/25

Last post

ASX News

527

RAC

Competition. Who replaces Prof Chen on the SAB

17/06/25

Last post The Knightrider

RAC

Ann: Race global agreement with City of Hope to access FTO IP

3 4 5

17/06/25

270

96K

17/06/25

Last post WilkensOne

270

96K

RAC

Pillar 1 - FTO (new thread)

50 51 52

16/06/25

3.1K

1.1M

16/06/25

Last post PuddleJump

3.1K

1.1M

RAC

Cardioprotection thread

18 19 20

15/06/25

1.1K

393K

15/06/25

Last post Roger233

1.1K

393K

RAC

Ann: Race Oncology 2024 Chairs Address and AGM Presentation

4 5 6

13/06/25

351

104K

13/06/25

Last post asx11

351

104K

RAC

Ann: First Patient Dosed Safely in RC220 Phase 1 Trial

2 3 4

12/06/25

201

70K

12/06/25

Last post Boffin99

201

70K

RAC

Ann: Application for quotation of securities - RAC

06/06/25

892

06/06/25

Last post easysell

892

RAC

Ann: Notification of cessation of securities - RAC

03/06/25

1.9K

03/06/25

Last post HeyLine

1.9K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Application for quotation of securities - RAC
19 Jun 14:35	Share

First Patient Safely Combine Dosed in Phase 1 RC220 Trial
19 Jun 08:56	Share

Termination of City of Hope Global IP License
17 Jun 08:57	Share

Application for quotation of securities - RAC
06 Jun 11:54	Share

Notification of cessation of securities - RAC
03 Jun 10:27	Share

Race Gold Coast Brisbane Investor Events
02 Jun 12:14	Share

Application for quotation of securities - RAC
29 May 16:11	Share

Application for quotation of securities - RAC
22 May 11:14	Share

Application for quotation of securities - RAC
07 May 11:09	Share

Notification of cessation of securities - RAC
06 May 15:51	Share

Race Announces Key Senior Clinical Team Appointments
05 May 08:57	Share

First Patient Dosed Safely in RC220 Phase 1 Trial
01 May 08:57	Share

March 2025 Quarterly Activity Report and Appendix 4C
23 Apr 08:41	Share

Enrolment Opened at Second Site for RC220 Phase 1 Trial
22 Apr 08:56	Share

RC220 Phase 1 Trial Opens for Patient Enrolment
03 Apr 08:57	Share

Ethics approval for RC220 Trial at Gosford Wyong Hospitals
31 Mar 17:41	Share

Race Initiates First AU Site for Phase 1 Solid Tumour Trial
27 Mar 15:53	Share

Race Investor Presentation
17 Mar 16:53	Share

Race Online Investor Briefing Invitation
14 Mar 11:08	Share

Ethics approval received for RC220 Phase 1 Trial
14 Mar 08:47	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Race Signs Contract for Phase 1 Trial of RC220
05 Mar 08:58	Share

Appendix 4D & Half-Year Financial Statements
25 Feb 13:42	Share

Application for quotation of securities - RAC
04 Feb 13:06	Share

Quarterly Activity Report and Appendix 4C
31 Jan 08:57	Share

Application for quotation of securities - RAC
16 Jan 15:57	Share

Appendix 3X - Dr Megan Baldwin
02 Jan 08:22	Share

Race Strengthens Board
18 Dec 08:53	Share

Race Receives $5.25m RD Tax Refund for Financial Year 2024
17 Dec 10:26	Share

Race Submits Human Ethics for RC220 Phase 1 Trial
05 Dec 08:44	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.34		Change -0.015(1.11%)		Mkt cap ! $231.9M

Open	High	Low	Value	Volume
$1.35	$1.36	$1.31	$132.3K	98.59K

Buyers (Bids)

No.	Vol.	Price($)
1	20000	$1.32

Sellers (Offers)

Price($)	Vol.	No.
$1.34	10069	2

View Market Depth

No.	Vol.	Price($)
1	20000	1.315
1	1849	1.310
1	2000	1.305
1	5000	1.290
3	21173	1.280

Price($)	Vol.	No.
1.335	10069	2
1.350	1000	1
1.385	2000	1
1.390	11231	2
1.400	7060	2

Last trade - 15.54pm 20/06/2025 (20 minute delay)

RAC (ASX) Chart

RACE ONCOLOGY LTD

Corporate Spotlight

Latest Threads

Thick, High-Grade Gold Intercepts Demonstrate Robustness of Apollo Hill Resource

Corporate Spotlight

Timeline

Featured News

Latest Videos

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

14 May 2024 09:56 (AEST)

Race Oncology (ASX:RAC) strikes contracts to start observational breast cancer trial

13 Mar 2023 15:00 (AEDT)

Race Oncology (ASX:RAC) enters new collaboration investigating heart protection during chemo

02 Mar 2023 15:49 (AEDT)

Latest Articles

Race Oncology approved for Phase I trial for chemotherapeutic treatments

Race Oncology Ltd has received approval to go ahead with its Phase I trial to assess R220 and begin enrolling patients

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University in Melbourne

Race delivers promising results in cancer drug mice research into heart complications

Race Oncology (ASX:RAC) has announced a preclinical breakthrough in heart toxicity side effects caused by the carfilzomib, which had precluded the drug being administered to patients diagnosed with elevated cardiac risk factors.In work performed under contract by Labcorp in the United States, Rac...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News